文献速递免疫规划传染病防控与疫情报告

基于GEM表面展示系统的PEDV刺突蛋白亚单位疫苗诱导稳健免疫反应

Robust immunoreaction induced by a subunit vaccine of PEDV spike protein based on GEM surface-display system.
PubMed 文献 · Vaccine · 2026-01-08

本研究将猪流行性腹泻病毒(PEDV)刺突(S)蛋白通过蛋白锚(PA)展示在革兰阳性菌增强基质(GEM)颗粒上,构建GEM-S亚单位疫苗,并在小鼠中评估免疫原性。与可溶性S蛋白相比,GEM-S和油佐剂对照206-S均上调细胞因子/趋化因子表达、增加淋巴结抗原提呈细胞、增强树突状细胞共刺激分子表达并提高全身抗体滴度。GEM-S较206-S诱导更高IgG2a/IgG1比值、更强肠道黏膜IgA和更持久抗体反应,但总IgG水平较低。

要点

  • GEM-S颗粒疫苗可有效诱导小鼠PEDV特异性体液和黏膜免疫应答。
  • GEM-S较油佐剂206-S诱导更高IgG2a/IgG1比值和更强肠道黏膜IgA。
  • GEM-S总IgG水平低于206-S,但抗体反应更持久。

核心结论

  • GEM-S颗粒制剂能在小鼠中有效激发稳健的PEDV特异性体液和黏膜免疫反应,支持其作为PEDV亚单位疫苗候选进一步研究。

研究设计与样本

  • 将PEDV S蛋白通过蛋白锚展示在GEM颗粒上构建GEM-S亚单位疫苗,并在小鼠中评估免疫原性。
  • 采用RT-qPCR、流式细胞术、ELISA和病毒中和试验评估淋巴结、脾和血清免疫应答。

主要发现

  • 与可溶性S蛋白相比,GEM-S和油佐剂对照206-S均显著上调细胞因子/趋化因子表达。
  • GEM-S和206-S均增加淋巴结抗原提呈细胞数量、增强树突状细胞共刺激分子表达并提高全身抗体滴度。
  • GEM-S较206-S诱导更高IgG2a/IgG1比值、更强肠道黏膜IgA产生和更持久抗体反应,但总IgG水平较低。

临床怎么用

  • 提示GEM表面展示颗粒化抗原可作为PEDV亚单位疫苗的备选技术路线,但尚需进一步临床前与临床研究验证。

局限性

  • 免疫原性评估仅在小鼠中进行,尚未在目标猪群验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The global porcine epidemic diarrhea (PED) pandemic underscores the urgent need for safe, effective, and readily deployable subunit vaccines against porcine epidemic diarrhea virus (PEDV). In this study, we developed a subunit vaccine by displaying the PEDV spike (S) protein on Gram-positive enhancer matrix (GEM) particles via a protein anchor (PA), resulting in stable particulate antigen complexes designated GEM-S. The immunogenicity of GEM-S was evaluated in mice. Immune responses in lymph nodes (LNs), spleen, and serum were assessed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR), flow cytometry, enzyme-linked immunosorbent assay (ELISA), and virus neutralization assays. Compared to soluble S protein, both GEM-S and the oil-adjuvanted control 206-S significantly upregulated cytokine/chemokine expression, increased antigen-presenting cell (APC) numbers in LNs, enhanced co-stimulatory molecule expression on dendritic cells (DCs), and elevated systemic antibody titers. Notably, GEM-S induced a higher IgG2a/IgG1 ratio, stronger intestinal mucosal IgA production, and a more sustained antibody response than 206-S, despite generating lower total IgG levels. These findings indicate that the particulate GEM-S formulation can effectively elicit robust PEDV-specific humoral and mucosal immune responses in mice, supporting its further investigation as a promising subunit vaccine candidate against PEDV.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Qiao X, Du L, Qin Z, et al. Robust immunoreaction induced by a subunit vaccine of PEDV spike protein based on GEM surface-display system. Vaccine. 2026. PMID: 41512503. doi:10.1016/j.vaccine.2026.128204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。